You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neurofibroma

Showing 26 - 50 of 205
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Data Collected From Individuals Administered Neurobehavioral

Enrolling by invitation
  • HIV
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Neurofibromatosis 1, NF1, Neurofibromatosis Type 1 Trial in Chicago

    Recruiting
    • Neurofibromatosis 1
    • +2 more
      • Chicago, Illinois
        Ann & Robert H. Lurie Children's Hospital of Chicago
      Mar 11, 2022

      Patients With PN NF1 Starting Selumetinib in Russia

      Recruiting
      • Neurofibroma
        • Moscow, Moskva, Russian Federation
        • +9 more
        Jun 4, 2023

        PASS of Paediatric Patients Initiating Selumetinib

        Recruiting
        • Neurofibromatosis Type 1
          • Angers, France
          • +3 more
          Jan 12, 2023

          Neurofibromatosis 1 Trial in Boston (Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser)

          Not yet recruiting
          • Neurofibromatosis 1
          • Deoxycholic Acid
          • +3 more
          • Boston, Massachusetts
            Wellman Center for Photomedicine
          Nov 13, 2023

          Neurofibromatosis Type 1 Trial in Worldwide (Selumetinib)

          Active, not recruiting
          • Neurofibromatosis Type 1
          • Rochester, Minnesota
          • +8 more
          Nov 10, 2022

          Neurofibromatosis 1, Plexiform Neurofibromas Trial in Shanghai (HL-085)

          Recruiting
          • Neurofibromatosis 1
          • Plexiform Neurofibromas
          • Shanghai, Shanghai, China
            Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
          Apr 10, 2022

          Neurofibromatosis Type 1, Plexiform Neurofibroma, Optic Nerve Glioma Trial in London (Selumetinib)

          Recruiting
          • Neurofibromatosis Type 1
          • +2 more
          • London, United Kingdom
          • +1 more
          Nov 11, 2021

          Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

          Recruiting
          • Neurofibromatosis 1
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 20, 2023

          89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

          Recruiting
          • Neurofibromatosis 2
          • Bevacizumab Zirconium Zr-89
          • Leiden, Zuid-Holland, Netherlands
            Leiden University Medical Center
          Jan 5, 2023

          Parenting, Alopecia, Skin Condition Trial in Cardiff (Mindful Parenting Programme)

          Recruiting
          • Parenting
          • +6 more
          • Mindful Parenting Programme
          • Cardiff, United Kingdom
            Cardiff University
          Mar 9, 2023

          Stressors in Parents of Cancer or Neurofibromatosis Type 1 (NF1)

          Completed
          • Parents of Children With Cancer
          • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 26, 2023

            Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, Histiocytic Tumor, Other MAP-K Pathway Driven Diseases Trial

            Available
            • Neurofibromatosis Type 1-Associated Plexiform Neurofibromas
            • +2 more
            • Mirdametinib (MEK Inhibitor)
            • (no location specified)
            Aug 24, 2021

            Neurofibromatosis Type 1 Trial in Japan (Selumetinib)

            Active, not recruiting
            • Neurofibromatosis Type 1
            • Minato-ku, Japan
            • +3 more
            Jun 9, 2022

            Neurofibromatosis 1 Trial in Baltimore, Redwood City

            Recruiting
            • Neurofibromatosis 1
              • Baltimore, California
              • +1 more
              Aug 17, 2022

              Neurofibromatosis 1 Trial (curcumin, high phenolic extra virgin olive oil (HP-EVOO))

              Recruiting
              • Neurofibromatosis 1
              • curcumin, high phenolic extra virgin olive oil (HP-EVOO)
              • Minneapolis, Minnesota
                Masonic Cancer Center, University of Minnesota
              Aug 23, 2022

              Validating Pain Scales in Children and Young Adults

              Recruiting
              • Sickle Cell Disease
              • +3 more
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center, 9000 Rockville Pi
                Aug 24, 2022

                PET/MRI in CNS and Extra-CNS Tumors of Neurofibromatosis-1 (NF1)

                Completed
                • Neurofibromatosis-1
                • +2 more
                  • Chapel Hill, North Carolina
                    University of North Carolina-Chapel Hill
                  May 11, 2021

                  Neurofibromatosis 1, Plexiform Neurofibroma (PN) Trial in Worldwide (Selumetinib, Placebo)

                  Recruiting
                  • Neurofibromatosis 1
                  • Plexiform Neurofibroma (PN)
                  • Gainesville, Florida
                  • +40 more
                  Jan 16, 2023

                  Neurofibromatosis Type 1 Trial in Los Angeles (Whole-body Magnetic Resonance Imaging)

                  Recruiting
                  • Neurofibromatosis Type 1
                  • Whole-body Magnetic Resonance Imaging
                  • Los Angeles, California
                    Cedars Sinai Medical Center
                  Jul 11, 2022

                  Neurofibromatosis 1, Chronic Pain Trial in New Haven (iCanCope, iCanCope+Contingency Management)

                  Completed
                  • Neurofibromatosis 1
                  • Chronic Pain
                  • iCanCope
                  • iCanCope+Contingency Management
                  • New Haven, Connecticut
                    Frank D Buono, PHD
                  Sep 13, 2022

                  Neurofibromatosis 1, Neurofibroma, Atypical Neurofibroma Trial in Washington (Whole Body MRI)

                  Active, not recruiting
                  • Neurofibromatosis 1
                  • +5 more
                  • Whole Body MRI
                  • Washington, District of Columbia
                    Children's National Health System
                  Feb 26, 2021

                  Frameshift Peptides of Children With NF1

                  Completed
                  • Neurofibromatosis Type 1
                  • Frameshift Array blood sample test
                  • Washington, District of Columbia
                  • +2 more
                  Aug 29, 2022

                  Measures in Neurofibromatosis 1: Test- Retest

                  Suspended
                  • Neurofibromatosis Type 1
                  • Outcome measures
                  • London, United Kingdom
                    Guy's Hospital
                  Dec 23, 2021

                  NEUROFIBROMATOSIS 1 Trial in Milwaukee (aminolevulinic acid)

                  Recruiting
                  • NEUROFIBROMATOSIS 1
                  • aminolevulinic acid
                  • Milwaukee, Wisconsin
                    The Medical College of Wisconsin
                  Nov 30, 2021